Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001623632-25-000780
Filing Date
2025-07-08
Accepted
2025-07-08 07:30:44
Documents
5

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11070
2 eyepointamend1exhibit1.htm EX-99 11228
3 eyepointamend1exhibit2.htm EX-99 14329
4 eyepointamend1exhibit3trd.htm EX-99 4194
5 eyepointamend1exhibit3acd.htm EX-99 4154
  Complete submission text file 0001623632-25-000780.txt   47245
Mailing Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222
Business Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222 4122881900
FEDERATED HERMES, INC. (Filed by) CIK: 0001056288 (see all company filings)

EIN.: 251111467 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 480 PLEASANT STREET SUITE C400 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE C400 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-81613 | Film No.: 251109525
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)